TABLE 2.
Resistance profiles of Citrobacter spp. included in this study
| Molecules | Resistance rates (%) | ||
|---|---|---|---|
| β-Lactams | Ra | Ia | Sa |
| Ticarcillin | 100 | N/Ab | 0.0 |
| Ticarcillin-clavulanate | 100 | N/A | 0.0 |
| Piperacillin-tazobactam | 99.4 | N/A | 0.6 |
| Temocillin | 97.9 | 2.1 | 0.0 |
| Mecillinam | 32.1 | N/A | 67.9 |
| Cefotaxime | 86.8 | 2.6 | 10.6 |
| Ceftazidime | 85.2 | 1.8 | 13.0 |
| Ceftazidime-avibactam | 17.4 | N/A | 82.6 |
| Ertapenem | 91.2 | N/A | 8.8 |
| Meropenem | 11.4 | 22.0 | 66.6 |
| Imipenem | 13.2 | 14.8 | 72.0 |
| Aminoglycosides | |||
| Amikacin | 21.4 | N/A | 78.6 |
| Gentamicin | 69.6 | N/A | 30.4 |
| Fluoroquinolones | |||
| Ciprofloxacin | 81.0 | 4.8 | 14.2 |
| Levofloxacin | 73.5 | 5.2 | 21.3 |
| Others | |||
| Tigecycline | 7.6 | N/A | 92.4 |
| Sulfamethoxazole/trimethoprim | 65.8 | 1.1 | 33.1 |
| Fosfomycin | 9.3 | N/A | 90.7 |
a
S, susceptible; I, susceptible at high exposure; R, resistant.
b
N/A, not available.